Controlled trial of nimodipine in subarachnoid hemorrhage

Completed

Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Neurologically normal patients with intracranial aneurysms, able to begin treatment within 96 hours of subarachnoid hemorrhage, between 15 and 80 years of age.